The Effects of Green Tea and Salvadora Persica L. in Patients With Gingivitis
NCT ID: NCT06211309
Last Updated: 2024-01-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE2
45 participants
INTERVENTIONAL
2024-01-01
2024-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Anti Plaque Efficacy of Salvadora Persica L. and Green Tea Mouthwash
NCT03790904
Green Tea Mouthwash on Generalized Plaque- Induced Gingivitis
NCT04484792
Efficacy of Green and White Tea Extract Mouthwashes in the Management of Plaque-induced Gingivitis: A Clinical and Biochemical Study
NCT05861206
Efficacy of Matcha Tea on Patients With Biofilm-induced Gingivitis
NCT06912958
A Comparison of Chlorhexidine and Green Tea Mouthwash in Patients With Gingivitis and Their Salivary Neutrophil and TAC Levels
NCT06875440
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The plaque control is considered the most important preventive factor concerning caries, gingivitis, and periodontitis Mechanical means of plaque control, e.g. tooth brushing, flossing and use of other mechanical devices are the most commonly used methods. However, ideal plaque control solely by mechanical means requires a significant effort and is difficult to achieve.This has led to the introduction of chemical methods of plaque control using antimicrobial agentsMore specifically, chemotherapeutic agents with antimicrobial properties, such as 0.12% chlorhexidine (CHX), have been proposed as an adjunct to the standard oral hygiene protocol. chx has side effects encourage the need to develop alternative mouthwashes with similar efficacy but without these issues.
Hence the mouthwash enriched with a combination of aqueous extracts of Salvadora persica L. and green tea used as a substitution to CHX with minimal side effects .
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
co.mouthwash
15ml twice a day, rinse for 30sec refrain from eating or drinking for 30min
co.mouthwas
15ml twice a day, rinse for 30sec refrain from eating or drinking for 30min
Kin mouthwash
15ml twice a day, rinse for 30sec refrain from eating or drinking for 30min
Kin
15ml twice a day, rinse for 30sec refrain from eating or drinking for 30min
Distilled water
15ml twice a day, rinse for 30sec refrain from eating or drinking for 30min
Distilled water
15ml twice a day, rinse for 30sec refrain from eating or drinking for 30min
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
co.mouthwas
15ml twice a day, rinse for 30sec refrain from eating or drinking for 30min
Kin
15ml twice a day, rinse for 30sec refrain from eating or drinking for 30min
Distilled water
15ml twice a day, rinse for 30sec refrain from eating or drinking for 30min
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Participants who were apparently systemically healthy.
3. Not taking antibiotic and anti-inflammatory drugs in the last three months
4. Patients having generalized gingivitis with intact periodontium in which they have more than 30% bleeding sites with no PPD \>3 mm with no clinical attachment loss according to criteria proposed by
Exclusion Criteria
2. Those currently using any mouthwash.
3. Those on antibiotic therapy, anti-inflammatory medications or NSAID during the study and at the last 3 months before the study.
4. Those having a history of hypersensitivity to any product used in the present study.
5. Those having periodontitis.
6. Those who smoker or alcoholism.
7. handicapped patient or patients with limited manual dexterities.
8. pregnant , lactating women or taking contraceptive pills.
9. Subjects wearing orthodontic appliances or removable dentures.
10. patients unwilling to participate in study.
15 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Baghdad
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Aliaa Saeed Salman
principal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aliaa
Baghdad, , Iraq
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
857623
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.